Novel antifungal agents and their activity against aspergillus species

18Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

Abstract

There is a need for new antifungal agents, mainly due to increased incidence of invasive fungal infections (IFI), high frequency of associated morbidity and mortality and limitations of the current antifungal agents (e.g., toxicity, drug–drug interactions, and resistance). The clinically available antifungals for IFI are restricted to four main classes: polyenes, flucytosine, triazoles, and echinocandins. Several antifungals are hampered by multiple resistance mechanisms being present in fungi. Consequently, novel antifungal agents with new targets and modified chemical structures are required to combat fungal infections. This review will describe novel antifungals, with a focus on the Aspergillus species.

Cite

CITATION STYLE

APA

Vahedi-Shahandashti, R., & Lass-Flörl, C. (2020). Novel antifungal agents and their activity against aspergillus species. Journal of Fungi. MDPI AG. https://doi.org/10.3390/jof6040213

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free